X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ROYALGAZETTE.COM - A la Une - 26/12/2024 17:00

Nasdaq de-lists Altamira shares

The common shares of Altamira Therapeutics Ltd, the Bermudian-headquartered biotechnology company, have been de-listed from Nasdaq for failure to comply with the exchange’s rule that listed securities...

Articles similaires

Nasdaq de-lists Altamira shares

royalgazette.com - 26/12/2024 17:00

The common shares of Altamira Therapeutics Ltd, the Bermudian-headquartered biotechnology company, have been de-listed from Nasdaq for failure to...

SiriusPoint in $733m stock deal

royalgazette.com - 01/Jan 18:00

SiriusPoint Ltd, the Bermudian-headquartered global specialty insurer and reinsurer, has agreed to repurchase all SiriusPoint common shares and...

SiriusPoint in $733m stock deal

royalgazette.com - 01/Jan 18:00

SiriusPoint Ltd, the Bermudian-headquartered global specialty insurer and reinsurer, has agreed to repurchase all SiriusPoint common shares and...

Company hit with $600,000 penalty for regulation failures

royalgazette.com - 31/12/2024 08:08

A Bermudian-based company has been hit with civil penalties totalling $600,000 for failing to fully comply with financial regulations. In a statement...

Vantage Drilling in joint venture with France’s TotalEnergies

royalgazette.com - 06/Jan 14:18

Vantage Drilling International Ltd, the Bermudian-registered exempted company, has announced a joint venture with TotalEnergies, the...

AOG reports $3.4m net income

royalgazette.com - 01/Jan 11:32

American Overseas Group Ltd, the Bermudian-based holding company, has reported consolidated net income available to common shareholders of $3.4...

AOG reports $3.4m net income

royalgazette.com - 01/Jan 11:32

American Overseas Group Ltd, the Bermudian-based holding company, has reported consolidated net income available to common shareholders of $3.4...

Sorry! Image not available at this time

VR Resources Closes Non-Brokered Flow Through Private Placement

financialpost.com - 27/12/2024 22:30

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH...

Sorry! Image not available at this time

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

drugs.com - 02/Jan 22:01

SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and...

Sorry! Image not available at this time

Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

drugs.com - 02/Jan 22:01

SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and...

Les derniers communiqués

  • Aucun élément